Greater effect of stroke thrombolysis in the presence of arterial obstruction

Annals of Neurology

Volumn 70, Issue 4, 2011, Pages 601-605

  De Silva, Deidre A ^a   Churilov, Leonid ^b,c   Olivot, Jean Marc ^d   Christensen, Soren ^c   Lansberg, Maarten G ^d   Mlynash, Michael ^d   Campbell, Bruce C V ^c   Desmond, Patricia ^c   Straka, Matus ^d   Bammer, Roland ^d   Albers, Gregory W ^d   Davis, Stephen M ^c   Donnan, Geoffrey A ^b,c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; SCINTIGRAPHY; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; COMORBIDITY; FIBRINOLYTIC THERAPY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; STROKE; TIME;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; COMORBIDITY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84855394281     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22444     Document Type: Article

References (14)

1. Lansberg MG, Schrooten M, Bluhmki E, et al. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke 2009;40:2079-2084.
2. De Silva DA, Fink JN, Christensen S, et al. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke 2009;40:2872-2874.
3. Marks MP, Olivot JM, Kemp S, et al. Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: Correlations between MR angiography findings and perfusion-and diffusion-weighted imaging in the DEFUSE study. Radiology 2008;249: 614-623.
4. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusiondiffusion weighted imaging or perfusion CT (DIAS-2): A prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141-150.
5. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
6. The Internet Stroke Center. Stroke Trials Registry. DIAS-3 Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke. Available at: Http://www.strokecenter.org/trials/trialdetail.aspx?tid =914. Accessed April 12, 2011.
7. The Internet Stroke Center. Stroke Trials Registry. DIAS-4 Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke. Available at: Http://www.strokecenter.org/trials/TrialDetail.aspx? tid=961. Accessed April 12, 2011.
8. Liu Y, Karonen JO, Vanninen RL, et al. Acute ischemic stroke: Predictive value of 2D phase-contrast MR angiography-serial study with combined diffusion and perfusion MR imaging. Radiology 2004;231:517-527. (Pubitemid 38552913)
9. Barber PA, Davis SM, Darby DG, et al. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology 1999;52:1125-1132. (Pubitemid 29177910)
10. Rother J, Schellinger PD, Gass A, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke
11. Fiehler J, Knudsen K, Thomalla G, et al. Vascular occlusion sites determine differences in lesion growth from early apparent diffusion coefficient lesion to final infarct. Am J Neuroradiol 2005;26: 1056-1061. (Pubitemid 43821948)
12. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309.
13. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60: 508-517. (Pubitemid 44871793)
14. Staroselskaya IA, Chaves C, Silver B, et al. Relationship between magnetic resonance arterial patency and perfusion-diffusion mismatch in acute ischemic stroke and its potential clinical use. Arch Neurol 2001;58:1069-1074. (Pubitemid 32660769)